How chromatin affects gene regulation in stem cells
Chromatin-mediated mechanisms of transcription regulation in ES cells
This study is looking at how certain parts of our DNA help control how stem cells develop into different types of cells, which could lead to new treatments for various diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10840676 on NIH RePORTER |
What this research studies
This research investigates the role of chromatin in regulating gene expression in embryonic stem cells, which have the ability to develop into any cell type in the body. By understanding how chromatin structure influences stem cell identity and differentiation, the research aims to uncover mechanisms that could direct stem cells towards specific cell types for therapeutic purposes. The study focuses on the function of chromatin regulatory factors and non-coding RNAs in gene regulatory networks, which are crucial for proper cell development and function. Through a series of experiments, the researchers will explore how these factors contribute to cellular processes and their implications in various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from stem cell therapies, particularly those related to developmental disorders.
Not a fit: Patients with conditions that do not involve stem cell differentiation or chromatin-related mechanisms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advancements in targeted therapies for a range of diseases by improving our understanding of stem cell differentiation.
How similar studies have performed: Previous research has shown promising results in understanding chromatin's role in gene regulation, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Hainer, Sarah Jane — University of Pittsburgh at Pittsburgh
- Study coordinator: Hainer, Sarah Jane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.